Consequently, this therapeutic area is no longer a priority for many companies (timeline). Nevertheless, recent market events suggest that allergic rhinitis should still be monitored by drug ...

Objective: To compare loratadine with fexofenadine and placebo in relieving symptoms of seasonal allergic rhinitis (SAR ... relief versus placebo: both agents provided similar reductions from ...

The precise mechanism of corticosteroid action on allergic rhinitis is not known ... consider anti-infective prophylactic therapy. Recent nasal septum ulcers, nasal surgery, or nasal trauma ...

Mwikali is now forced to use steroid inhalers as the mode of therapy ... now say allergic rhinitis refers to inflammation of the nasal lining and follows exposure to allergy-causing agents ...

For patients with severe symptoms, the combination could be started as first-line therapy, but azelastine has a bitter taste, and two different sprays increase treatment cost and complexity.